RayzeBio (RYZB) - P/E ratio

This company appears to have been delisted
Reason: Acquired by Bristol Myers Squibb
Last recorded trade on: April 26, 2024
Source: https://news.bms.com/news/details/2024/Bristol-Myers-Squibb-Completes-Acquisition-of-RayzeBio-Adding-Differentiated-Actinium-Based-Radiopharmaceutical-Platform/default.aspx

RayzeBio

RYZB

#3555

Rank

NZ$6.37 B

Marketcap

🇺🇸 United States

Country

NZ$106.26

Share price

0.00%

Change (1 day)

N/A

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions